Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionFirst Trust Advisors Lp
Latest Disclosed Ownership2,173,376 shares
Latest Disclosed Value $ 87,608,786
First Trust Advisors Lp reports 213.48% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 13, 2026 - First Trust Advisors Lp filed a 13F-HR form disclosing ownership of 2,173,376 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $74,959,738 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 693,317 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 213.48% during the quarter. The current value of the position is $137,444,298 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,173,376 1,480,059 213.48 87,609 263.11 0.0624
2026-02-13 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 693,317 -26,907 -3.74 24,127 -59.69 0.0175
2025-11-12 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 720,224 183,038 34.07 59,858 51.81 0.0445
2025-08-13 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 537,186 -387,131 -41.88 39,429 -62.65 0.0317
2025-05-14 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 924,317 -139,805 -13.14 105,575 96.89 0.0935
2025-02-13 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,064,122 -254,015 -19.27 53,621 -12.10 0.0473
2024-11-13 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,318,137 -203,471 -13.37 61,003 23.40 0.0581
2024-08-13 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,521,608 -317,204 -17.25 49,437 6.73 0.0504
2024-05-13 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,838,812 1,691,804 1,150.82 46,320 870.23 0.0470
2024-02-13 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 147,008 61,826 72.58 4,775 105.78 0.0052
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 85,182 70,840 493.93 2,321 627.27 0.0028
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 14,342 -24,835 -63.39 319 -62.38 0.0004
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,177 -108,741 -73.51 849 -71.77 0.0010
2023-02-09 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 147,918 74,667 101.93 3,004 59.96 0.0036
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 73,251 -24,068 -24.73 1,878 -18.84 0.0024
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 97,319 6,615 7.29 2,314 13.26 0.0029
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 90,704 41,687 85.05 2,043 110.40 0.0021
2022-02-08 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 49,017 33,446 214.80 971 217.32 0.0009
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 15,571 -69,480 -81.69 306 -83.65 0.0003
2021-10-12 2021-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 85,051 -127,267 -59.94 1,871 -62.96 0.0020
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 85,051 -127,267 1,871 0.0019
2021-05-14 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 212,318 114,586 117.25 5,051 97.54 0.0061
2021-02-02 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 97,732 -46,110 -32.06 2,557 2.12 0.0034
2020-11-05 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 143,842 -15,467 -9.71 2,504 -6.57 0.0040
2020-07-22 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 159,309 101,230 174.30 2,680 287.84 0.0046
2020-05-06 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 58,079 -189,444 -76.54 691 -76.93 0.0016
2020-02-03 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 247,523 198,126 401.09 2,995 329.08 0.0051
2019-11-04 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 49,397 37,100 301.70 698 409.49 0.0013
2019-07-30 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 12,297 -154,534 -92.63 137 -93.01 0.0003
2019-06-19 2019-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 166,831 166,831 1,959 0.0039
2019-05-09 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 166,831 166,831 1,959
2019-02-07 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -76,108 -100.00 0 -100.00
2018-10-25 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 76,108 2,456 3.33 1,067 -7.86 0.0020
2018-08-02 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 73,652 -56,514 -43.42 1,158 -45.91 0.0024
2018-04-23 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 130,166 -18,099 -12.21 2,141 -20.05 0.0049
2018-02-08 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 148,265 -57,547 -27.96 2,678 -32.58 0.0064
2017-10-24 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 205,812 -4,649 -2.21 3,972 59.97 0.0102
2017-08-02 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 210,461 210,461 2,483 0.0066
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.